Virtus ETF Advisers’s Sangamo Therapeutics SGMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-29,327
Closed -$51.6K 478
2023
Q1
$51.6K Sell
29,327
-11,273
-28% -$19.8K 0.03% 429
2022
Q4
$127K Buy
40,600
+8,949
+28% +$28.1K 0.07% 396
2022
Q3
$155K Buy
31,651
+227
+0.7% +$1.11K 0.06% 348
2022
Q2
$130K Buy
31,424
+10,441
+50% +$43.2K 0.05% 352
2022
Q1
$122K Sell
20,983
-1,244
-6% -$7.23K 0.05% 267
2021
Q4
$167K Buy
22,227
+4,141
+23% +$31.1K 0.06% 301
2021
Q3
$163K Sell
18,086
-951
-5% -$8.57K 0.07% 320
2021
Q2
$228K Sell
19,037
-3,913
-17% -$46.9K 0.09% 250
2021
Q1
$288K Buy
22,950
+396
+2% +$4.97K 0.12% 248
2020
Q4
$352K Sell
22,554
-5,495
-20% -$85.8K 0.15% 168
2020
Q3
$265K Sell
28,049
-3,815
-12% -$36K 0.14% 250
2020
Q2
$286K Sell
31,864
-10,390
-25% -$93.3K 0.14% 307
2020
Q1
$269K Sell
42,254
-6,154
-13% -$39.2K 0.11% 241
2019
Q4
$405K Buy
48,408
+21,277
+78% +$178K 0.07% 250
2019
Q3
$246K Sell
27,131
-1,512
-5% -$13.7K 0.05% 215
2019
Q2
$308K Buy
+28,643
New +$308K 0.06% 204
2019
Q1
Sell
-26,120
Closed -$300K 247
2018
Q4
$300K Sell
26,120
-4,015
-13% -$46.1K 0.05% 111
2018
Q3
$511K Sell
30,135
-21,556
-42% -$366K 0.05% 117
2018
Q2
$734K Buy
51,691
+5,242
+11% +$74.4K 0.65% 80
2018
Q1
$883K Buy
46,449
+24,858
+115% +$473K 0.77% 61
2017
Q4
$354K Sell
21,591
-22,391
-51% -$367K 0.44% 83
2017
Q3
$660K Buy
43,982
+4,023
+10% +$60.4K 0.09% 73
2017
Q2
$352K Buy
+39,959
New +$352K 0.05% 85
2016
Q4
Sell
-41,249
Closed -$191K 187
2016
Q3
$191K Hold
41,249
0.09% 139
2016
Q2
$239K Buy
41,249
+12,188
+42% +$70.6K 0.18% 105
2016
Q1
$176K Sell
29,061
-1,786
-6% -$10.8K 0.24% 103
2015
Q4
$282K Buy
+30,847
New +$282K 0.77% 40